Emergent BioSolutions Company Profile

01:35 EST 11th December 2018 | BioPortfolio

Emergent BioSolutions Inc. is a biopharmaceutical company dedicated to one simple mission—to protect life. We develop, manufacture and commercialize immunobiotics, consisting of vaccines and therapeutics that assist the body’s immune system to prevent or treat disease. Our biodefense business focuses on immunobiotics for use against biological agents that are potential weapons of bioterrorism and biowarfare. Our marketed product, BioThrax® (Anthrax Vaccine Adsorbed), is the only vaccine approved by the U.S. Food and Drug Administration for the prevention of anthrax infection. In addition to BioThrax, our biodefense product portfolio includes a next generation anthrax vaccine program, which includes a product candidate in Phase I clinical development, and a botulism program with multiple product candidates in preclinical development. Our commercial business focuses on immunobiotics for use against infectious diseases and other medical conditions that have resulted in significant unmet or underserved public health needs. Our commercial product portfolio includes a typhoid vaccine candidate and a hepatitis B therapeutic vaccine candidate, both of which are in Phase II clinical development, a group B streptococcus vaccine candidate in Phase I clinical development and two vaccine candidates in preclinical development.


2273 Research Boulevard, Suite 400
United States of America


Phone: 301-795-1800
Fax: 301-795-1899

News Articles [109 Associated News Articles listed on BioPortfolio]

Emergent BioSolutions Aqcuires Adapt Pharma and its Flagship Product Narcan

News Emergent will acquire the Narcan Nasal Spray product and a development pipeline of new treatment and delivery options to address opioid overdose.

Emergent BioSolutions to acquire Adapt Pharma for up to $735m

Emergent BioSolutions has agreed to acquire Ireland-based Adapt Pharma for an upfront payment of $635m, followed by up to $100m...Read More... The post Emergent BioSolutions to acquire Adapt Pharma fo...

Deals this week: Emergent BioSolutions, Pediapharm, Adynxx

Emergent BioSolutions has acquired Adapt Pharma in a deal valued at up to $735m. Adapt Pharma will receive an upfront...Read More... The post Deals this week: Emergent BioSolutions, Pediapharm, Adynxx...

Emergent BioSolutions Expands Manufacturing Capability

NewsABEC’s Custom Single Run systems are expected to enhance Emergent BioSolutions’ manufacturing productivity, flexibility, and economies of scale.

Emergent BioSolutions Acquires Adapt Pharma in $735 Million Deal

Touting that it is helping fight the opioid epidemic, Emergent BioSolutions is acquiring Adapt Pharma. Under the terms of the deal, Emergent will pay $635 million up front and up to $100 million in ca...

Emergent BioSolutions Buys PaxVax for $270 Million

Emergent BioSolutions, headquartered in Gaithersburg, Maryland, inked a deal to buy PaxVax, based in Redwood City, California, for $270 million in cash.

Emergent BioSolutions to acquire Adapt Pharma

Emergent BioSolutions to acquire PaxVax

Emergent BioSolutions' agreement to acquire PaxVax will bring several specialty va

Drugs and Medications [32 Associated Drugs and Medications listed on BioPortfolio]

Artemis alcohol-free antiseptic foam hand sanitizer [Artemis Bio-Solutions Inc]

ARTEMIS ALCOHOL-FREE Antiseptic Foam Hand Sanitizer

Artemis alcohol-free antiseptic foam hand [Artemis Bio-Solutions Inc]

ARTEMIS ALCOHOL-FREE Antiseptic Foam Hand Soap

Alprazolam [Sun Pharma Global FZE]

Alprazolam Tablets, USP CIV

Zolpidem tartrate [NorthStar Rx LLC]

These highlights do not include all the information needed to use zolpidem tartrate safely and effectively. See full prescribing information for zolpidem tartrate tablets.Zolpidem Tartrate Tablets CIV...

Zaleplon [Greenstone LLC]

PubMed Articles [137 Associated PubMed Articles listed on BioPortfolio]

Laparoscopic versus open emergent ventral hernia repair: utilization and outcomes analysis using the ACSNSQIP database.

Laparoscopic ventral hernia repair (VHR) is associated with decreased morbidity and shorter length of stay (LOS) when compared to open VHR. Despite evidence of the benefits of laparoscopy, its utiliza...

Successful prevention of follicular rupture at 45 h after hCG and GnRHa triggering by emergent administration of indomethacin: A case report.

To report the management and prevention of pre-operative ovulation before oocyte retrieval with emergent administration of indomethacin.

Monopole-Induced Emergent Electric Fields in Ferromagnetic Nanowires.

We predict that complete magnetization reversal in simple metallic ferromagnetic nanoparticles is directly linked to the pair creation of topological point defects in the form of hedgehog-antihedgehog...

Social psychological research on prejudice as collective action supporting emergent ingroup members.

Why does social psychological research on prejudice change across time? We argue that scientific change is not simply a result of empirical evidence, technological developments, or social controversie...

Voices from the landscape: Storytelling as emergent counter-narratives and collective action from northern BC watersheds.

The 'Ecohealth and Watersheds in Northern BC'' project, situated in a resource rich, settler colonial context, generated three digital stories at the request of the project's Steering Committee member...

Clinical Trials [138 Associated Clinical Trials listed on BioPortfolio]

Multifactorial Approach to Emergent Cerclage

Though cervical insufficiency is a common cause of second trimester pregnancy loss, the placement of an emergent cerclage in these patients is thought to improve perinatal outcomes. It is ...

Pre-hospital and Intra-hospital Temporal Delays in Patients Requiring Emergent Trauma Craniotomy

The investigators aim to retrospectively map the delays in the acute care of traumatic brain injury patients necessitating emergent craniotomies.

Assessing Treatment Emergent Suicidal Ideation in Patients With Major Depression

This study will develop a new methodology to evaluate any treatment-emergent suicidal ideation that might occur when an antidepressant treatment has been started and/or during times when d...

Fixed Versus Variable Dosing of 4-factor Prothrombin Complex Concentrate for Emergent Warfarin Reversal

The goal of this study is to determine if a fixed dose of 4-factor prothrombin complex concentrate (4FPCC) is as effective as the current standard of care. 4FPCC is used to reverse the eff...

Safety of Sugammadex for the Reversal of Neuromuscular Blockade in American Society of Anesthesiologists (ASA) Class 3 or 4 Participants (MK-8616-145)

This is a randomized, active comparator-controlled, parallel-group, multi-site, double-blind safety trial of sugammadex (MK-8616) for the reversal of neuromuscular blockade (NMB) induced b...

Companies [35 Associated Companies listed on BioPortfolio]

Emergent BioSolutions Inc.

Emergent BioSolutions Inc. is a biopharmaceutical company focused on the development, manufacture and commercialization of vaccines and antibody therapies that assist the bodyâ€...

Fina Biosolutions LLC

Fina Biosolutions (Rockville, MD) is a privately held company providing technology, laboratory, and consulting services in the field of conjugate vaccines. Chemistry developed by ...

Immune Biosolutions Inc.

Immune Biosolutions (IBio) is an innovative biotech company specialized in the discovery and engineering of chicken humanized antibodies that target proteins with a recognized, ye...

Fina Biosolutions

Fina Biosolutions is a privately-owned R&D biotechnology company located in Rockville, MD. The company provides laboratory services and technology in the field of conjugate vaccin...

Emergent Health Corp.

Emergent Health Corp., a diversified biotechnology firm, is focused on the health and wellness industry. Using patented and patent pending nutritionally designed products, E...

More Information about "Emergent BioSolutions" on BioPortfolio

We have published hundreds of Emergent BioSolutions news stories on BioPortfolio along with dozens of Emergent BioSolutions Clinical Trials and PubMed Articles about Emergent BioSolutions for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Emergent BioSolutions Companies in our database. You can also find out about relevant Emergent BioSolutions Drugs and Medications on this site too.

Quick Search


Relevant Topics

Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

Corporate Database Quicklinks

Searches Linking to this Company Record